Psychostimulant addiction treatment
- PMID: 24727297
- PMCID: PMC4524548
- DOI: 10.1016/j.neuropharm.2014.04.002
Psychostimulant addiction treatment
Abstract
Treatment of psychostimulant addiction has been a major, and not fully met, challenge. For opioid addiction, there is strong evidence for the effectiveness of several medications. For psychostimulants, there is no corresponding form of agonist maintenance that has met criteria for regulatory approval or generally accepted use. Stimulant-use disorders remain prevalent and can result in both short-term and long-term adverse consequences. The mainstay of treatment remains behavioral interventions. In this paper, we discuss those interventions and some promising candidates in the search for pharmacological interventions. This article is part of the Special Issue entitled 'CNS Stimulants'.
Keywords: Addiction; Psychostimulant; Treatment.
Published by Elsevier Ltd.
References
-
- Al Suwaidi J, Ali WM, Aleryani SL. Cardiovascular complications of Khat. Clinica Chimica Acta. 2013;419:11–14. - PubMed
-
- Al’Absi M, Grabowski J. Concurrent use of tobacco and Khat: Added burden on chronic disease epidemic. Addiction. 2012;107(2):451–452. - PubMed
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous